NasdaqGS:MRNA (Moderna, Inc.)

About MRNA

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
  • Moderna, Inc. (NasdaqGS: MRNA) Latest News

    Investing Articles

    Is Moderna stock set for an explosive rise in 2023?

    Moderna stock is marching higher today after the company reported positive phase 3 data for its RSV vaccine. Can this…

    Read more »

    Growth Shares

    Can Moderna stock triple my money this year?

    Moderna stock has been plummeting. But with new treatments, one analyst is predicting a 300% jump. So, should I buy…

    Read more »

    Bournemouth at night with a fireworks display from the pier
    Investing Articles

    My 3 best stocks to buy in 2023

    Here's my three best stocks to buy this year. They're all down significantly from their all-time highs but still look…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    Best British growth stocks to buy for December

    We asked our freelance writers to reveal the top growth shares they’d buy in December, which included a rare double…

    Read more »

    Investing Articles

    Is it time to buy Moderna shares?

    Moderna shares have lost nearly 15% of their value over the last week. So is it time for me to…

    Read more »

    Investing Articles

    Is Moderna stock a buy?

    Moderna stock is rallying after a new strain of the Covid virus was announced. Dan Appleby looks at the company…

    Read more »

    Investing Articles

    What is the Moderna share price really worth?

    Rupert Hargreaves explains why he thinks the Moderna share price is attractively priced after the company's recent declines.

    Read more »

    Investing Articles

    I think these 2 S&P 500 stocks are severely overvalued

    S&P 500 stocks have soared in recent times, reaching new highs day-by-day. But I now think that these two growth…

    Read more »

    Investing Articles

    Should I buy Moderna for my Stocks and Shares ISA?

    Rupert Hargreaves explains why he thinks the Moderna share price could be an attractive acquisition for his Stocks and Shares…

    Read more »

    Investing Articles

    Moderna shares are beating the rest of the S&P 500. Am I buying?

    Moderna shares have had a fantastic 2021, and have risen far more than the rest of the S&P 500. After…

    Read more »

    Investing Articles

    Can the Moderna share price keep rising?

    The Moderna share price has surged more than 450% in 12 months. But this explosive growth may soon be over.…

    Read more »

    Investing Articles

    The Moderna share price has risen +400%: should I buy the stock now?

    With the continued vaccine rollout leading to a positive Q1, Charlie Keough assesses whether he sees long-term value in the…

    Read more »